Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Jianqiong, Yang"'
Autor:
Xiaoxuan Liu, Minhong Zhang, Xuelian Zhou, Mengjiao Wan, Aiping Cui, Bang Xiao, Jianqiong Yang, Hai Liu
Publikováno v:
Frontiers in Nutrition, Vol 11 (2024)
Zein is the main vegetable protein from maize. In recent years, Zein has been widely used in pharmaceutical, agriculture, food, environmental protection, and other fields because it has excellent biocompatibility and biosafety. However, there is stil
Externí odkaz:
https://doaj.org/article/9ad1ab03fdfe4453ba735b2f2f41abeb
Autor:
Binhui Xie, Baiyin Zhong, Zhenxian Zhao, Jie Hu, Jianqiong Yang, Yuankang Xie, Jianhong Zhang, Jianting Long, Xuewei Yang, Heping Li
Publikováno v:
Cancer & Metabolism, Vol 11, Iss 1, Pp 1-12 (2023)
Abstract Chemotherapy resistance is the leading cause for hepatocellular carcinoma (HCC)-induced death. Exploring resistance generation mechanism is an urgent need for HCC therapy. Here, we found STEAP4 was significantly downregulated in HCC patients
Externí odkaz:
https://doaj.org/article/84e7ae84c1034387ac442e633775ae0b
Autor:
Mingchun Li, Zhihua Liu, Zan Hou, Xiangcai Wang, Huaqiu Shi, Yamei Li, Xuewen Xiao, Zhixian Tang, Jianqiong Yang, Yaoling Luo, Minhong Zhang, Ming Chen
Publikováno v:
Thoracic Cancer, Vol 14, Iss 14, Pp 1223-1238 (2023)
Abstract Background Zinc finger protein 687 (ZNF687) has previously been discovered as a potential oncogene in individuals with giant cell tumors of the bone, acute myeloid leukemia, and hepatocellular carcinoma. However, its role and mechanism in lu
Externí odkaz:
https://doaj.org/article/d0eab200725b4321b7c043d6fca3b6ee
Publikováno v:
Drug Delivery, Vol 30, Iss 1 (2023)
AbstractAmphotericin B (AmB) is regarded as a first-line therapy against life-threatening invasive fungal infections. Due to its poor oral bioavailability, AmB is restricted to intravenous administration in clinical practice. As science continues to
Externí odkaz:
https://doaj.org/article/ffcbbbb50a594155b7731a1f3df533eb
Autor:
Jianqiong Yang, Bang Xiao, Yamei Li, Xiaoxuan Liu, Minhong Zhang, Yaoling Luo, Biao Wang, Hai Liu
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Renal cell carcinoma (RCC) is a common malignant tumor of the urinary system, which is highly invasive, metastatic, and insensitive to radiotherapy and chemotherapy. Chinese herbal medicine has always been an important source of anti-tumor drug devel
Externí odkaz:
https://doaj.org/article/3729da5849ee4db2907f2b9b9ee3c0c9
Autor:
Yamei Li, Hai Liu, Xiaoxuan Liu, Bang Xiao, Minhong Zhang, Yaoling Luo, Mingchun Li, Jianqiong Yang
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
The leading cause of cancer deaths is lung cancer, non-small cell lung cancer (NSCLC), the most common type of lung cancers, remains a difficult cancer to treat and cure. It is urgent to develop new products to treat NSCLS. Gracillin, extracted from
Externí odkaz:
https://doaj.org/article/c8262b07e00f48abaeb9e512d5ac990d
Autor:
Hai Liu, Jianqiong Yang, Yamei Li, Yunnan Ma, Wenjie Wang, Wanling Zhong, Pengyue Li, Shouying Du
Publikováno v:
Frontiers in Molecular Biosciences, Vol 8 (2022)
Thrombotic diseases have been considered major causes of death around the world. Treatments with thrombolytic drugs, such as recombinant tissue-plasminogen activator, urokinase, and streptokinase, are reported to have a life-threatening bleeding tend
Externí odkaz:
https://doaj.org/article/0bb12e4f8df94fd99c5a2da404188161
Autor:
Yamei Li, Yifang Yang, Xingdong Kang, Xiaofeng Li, Yongzhong Wu, Junping Xiao, Yang Ye, Jianqiong Yang, Yang Yang, Hai Liu
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2022)
Callicarpa nudiflora (C. nudiflora) is widely used to treat inflammation-related diseases in China. C. nudiflora mainly contains phenylethanol glycosides, flavonoids, triterpenes, diterpenes, iridoid glycosides, volatile oils, and other small molecul
Externí odkaz:
https://doaj.org/article/9f45716c26244738ae2dc108c4601a2f
Autor:
Minhong Zhang, Jianqiong Yang, Qian Liu, Hai Liu, Ling Cao, Biao Wang, Huamou Ma, Yamei Li, Xiaoliang Yuan
Publikováno v:
Drug Design, Development and Therapy
Jianqiong Yang,1,* Ling Cao,2,* Yamei Li,2,* Hai Liu,2,3,* Minhong Zhang,1 Huamou Ma,1 Biao Wang,1 Xiaoliang Yuan,4 Qian Liu5,6 1Department of Clinical Medicine Research Center, The First Affiliated Hospital of Gannan Medical University, Ganzhou, Jia
Publikováno v:
Drug Design, Development and Therapy. 14:551-565
Notoginsenoside (NG)-R1 is one of the main bioactive compounds from Panax notoginseng (PN) root, which is well known in the prescription for mediating the micro-circulatory hemostasis in human. In this article, we mainly discuss NG-R1 in metabolism a